StockClub

GLPGF

GLPGFLakefront Biotherapeutics$ --
Lakefront Biotherapeutics

Lakefront Biotherapeutics

GLPGF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
900M EUR
YoY +1092.8%
Operating Income
748M EUR
YoY +1292.8%
Net Income
782M EUR
YoY +2989.5%
EPS
11.86EUR
YoY +3989.7%

Revenue

EUR1.1B
FY2024 Q1EUR62.4M
EUR62.4M
Q1
FY2024 Q2EUR140.3M
EUR140.3M
Q2
FY2024 Q3EUR200.2M
EUR200.2M
Q3
FY2024 Q4EUR275.6M
EUR275.6M
Q4
FY2025 Q1EUR75M
EUR75M
Q1
FY2025 Q2EUR140.3M
EUR140.3M
Q2
FY2025 Q3EUR211.4M
EUR211.4M
Q3
FY2025 Q4EUR1.1B
EUR1.1B
Q4
Actual
+EUR836.3M (+303.4%)

Net Income

EUR320.6M
FY2024 Q1EUR90.2M
EUR90.2M
Q1
FY2024 Q2EUR99.2M
EUR99.2M
Q2
FY2024 Q3EUR48.8M
EUR48.8M
Q3
FY2024 Q4EUR74.1M
EUR74.1M
Q4
FY2025 Q1EUR-153.4M
EUR-153.4M
Q1
FY2025 Q2EUR-259.2M
EUR-259.2M
Q2
FY2025 Q3EUR-461.3M
EUR-461.3M
Q3
FY2025 Q4EUR320.6M
EUR320.6M
Q4
Actual
+EUR246.5M (+332.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:EUR478.1M
Est:EUR597.2M
FY2020MISS
EUR478.1M
FY2021MISS
Actual:EUR484.8M
Est:EUR547M
FY2021MISS
EUR484.8M
FY2022MISS
Actual:EUR505.3M
Est:EUR594.2M
FY2022MISS
EUR505.3M
FY2023MISS
Actual:EUR239.7M
Est:EUR561.2M
FY2023MISS
EUR239.7M
FY2024MISS
Actual:EUR275.6M
Est:EUR282.8M
FY2024MISS
EUR275.6M
FY2025BEAT
Actual:EUR1.1B
Est:EUR268.6M
FY2025BEAT
EUR1.1B

Analyst Estimates